Bone Therapeutics receives clearance
To investigate Allob’s potential to improve spinal fusion surgery outcomes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The politics behind pharma
Prime Minister Modi’s decision to review India’s position on IP laws before his first trip to the US has once again brought this…
Indian generic pharma and global regulatory challenges
Dr Gopakumar G Nair, Chief Executive Officer, Gopakumar Nair Associates talks about why the regulatory scenario in the domestic…
Pharma marketing In need of a reboot
Will China’s recent crackdown on the pharmaceutical industry’s unethical marketing practices result in any long lasting changes?…
Code of conduct: A pill to cure corrup
Unethical means of promotion employed by pharma firms have underlined the importance of a Uniform Code of Pharmaceutical Marketing…
Adopting new avenues
Pharma marketing is undergoing a metamorphosis, aided by digital technology which has not only opened up new vistas for brand…
‘Quality is a philosophy regardless of geographies’
Dr Alexandra Pearce, Senior Vice President and Head Global Regulatory Affairs - Glenmark Pharmaceuticals, talks about the…
Merck Serono partners with Sutro Biopharma
Merck Serono and Sutro Biopharma, San Francisco, a bio-pharmaceutical company developing antibody drug conjugates and bispecific…
Silver Leaf Oak acquires stake in Syngene International
The stake will be acquired from BRL at a valuation of Rs 3800 crores